Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Frydenberg

Showing results (61-70 of 182) with videos related to

Pageof 19
Sort By:
European Urology Focus|December 28, 2022
Quality Indicators in the Clinical Specialty of Urology: A Systematic ReviewHarvey Jia Wei Koh, Emma Whitelock-Wainwright, Dragan Gasevic, et al.
ANZ Journal of Surgery|June 21, 2021
Patient perceptions of surgical telehealth consultations during the COVID 19 pandemic in Australia: Lessons for future implementationElvina Wiadji, Lisa Mackenzie, Patrick Reeder, et al.
Stem Cells (Dayton, Ohio)|May 18, 2012
Human epithelial basal cells are cells of origin of prostate cancer, independent of CD133 statusRenea A Taylor, Roxanne Toivanen, Mark Frydenberg, et al.
Oncotarget|June 29, 2016
Obesity does not promote tumorigenesis of localized patient-derived prostate cancer xenograftsJennifer C Y Lo, Ashlee K Clark, Natasha Ascui, et al.
Psycho-Oncology|December 13, 2016
Trajectories of quality of life, life satisfaction, and psychological adjustment after prostate cancerSuzanne K Chambers, Shu Kay Ng, Peter Baade, et al.
Urologic Oncology|October 10, 2020
Trends in urologic oncology clinical practice and medical education under COVID-19 pandemic: An international survey of senior clinical and academic urologistsBarak Rosenzweig, Axel Bex, Zohar A Dotan, et al.
BJU International|March 31, 2012
Active surveillance for prostate cancer: an Australian experienceJoseph J Ischia, Chia Y Pang, Yeng K Tay, et al.
World Journal of Urology|December 18, 2016
Zero hospital admissions for infection after 577 transperineal prostate biopsies using single-dose cephazolin prophylaxisLana Pepdjonovic, Guan Hee Tan, Sean Huang, et al.
Science Translational Medicine|May 31, 2013
A preclinical xenograft model identifies castration-tolerant cancer-repopulating cells in localized prostate tumorsRoxanne Toivanen, Mark Frydenberg, Declan Murphy, et al.
BJU International|July 4, 2014
Medium-term oncological outcomes for extended vs saturation biopsy and transrectal vs transperineal biopsy in active surveillance for prostate cancerJames E Thompson, Andrew Hayen, Adam Landau, et al.
Pageof 19

Showing results (61-70 of 182) with videos related to

Sort By:
Pageof 19
European Urology Focus|December 28, 2022
Quality Indicators in the Clinical Specialty of Urology: A Systematic ReviewHarvey Jia Wei Koh, Emma Whitelock-Wainwright, Dragan Gasevic, et al.
ANZ Journal of Surgery|June 21, 2021
Patient perceptions of surgical telehealth consultations during the COVID 19 pandemic in Australia: Lessons for future implementationElvina Wiadji, Lisa Mackenzie, Patrick Reeder, et al.
Stem Cells (Dayton, Ohio)|May 18, 2012
Human epithelial basal cells are cells of origin of prostate cancer, independent of CD133 statusRenea A Taylor, Roxanne Toivanen, Mark Frydenberg, et al.
Oncotarget|June 29, 2016
Obesity does not promote tumorigenesis of localized patient-derived prostate cancer xenograftsJennifer C Y Lo, Ashlee K Clark, Natasha Ascui, et al.
Psycho-Oncology|December 13, 2016
Trajectories of quality of life, life satisfaction, and psychological adjustment after prostate cancerSuzanne K Chambers, Shu Kay Ng, Peter Baade, et al.
Urologic Oncology|October 10, 2020
Trends in urologic oncology clinical practice and medical education under COVID-19 pandemic: An international survey of senior clinical and academic urologistsBarak Rosenzweig, Axel Bex, Zohar A Dotan, et al.
BJU International|March 31, 2012
Active surveillance for prostate cancer: an Australian experienceJoseph J Ischia, Chia Y Pang, Yeng K Tay, et al.
World Journal of Urology|December 18, 2016
Zero hospital admissions for infection after 577 transperineal prostate biopsies using single-dose cephazolin prophylaxisLana Pepdjonovic, Guan Hee Tan, Sean Huang, et al.
Science Translational Medicine|May 31, 2013
A preclinical xenograft model identifies castration-tolerant cancer-repopulating cells in localized prostate tumorsRoxanne Toivanen, Mark Frydenberg, Declan Murphy, et al.
BJU International|July 4, 2014
Medium-term oncological outcomes for extended vs saturation biopsy and transrectal vs transperineal biopsy in active surveillance for prostate cancerJames E Thompson, Andrew Hayen, Adam Landau, et al.
Pageof 19